Atlas Trials

IL-2 Signaling and Polarization of Regulatory LBs: Involvement in Multiple Sclerosis

Clinical trial NCT04697407 · COMPLETED

Trial details

NCT number
NCT04697407
Sponsor
Rennes University Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Multiple Sclerosis
Start date
2021-03-23
Primary completion
2023-05-23
Enrollment
95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.